94D-33890-29757
4 vaccinations
10 coded responses
46 check-ins
10 free-text entries
3 call cases
- Sex
- Male
- Age at first dose
- 66+
- ZIP prefix
- 781 / TX
- Registered
- 2021-03-01
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-01
Registered in v-safe
-
2021-03-01
Dose 1 — Moderna
- 2021-03-01
-
2021-03-02
Survey response — days 1–6 daily, dose 1MedDRA: No adverse event, Unevaluable event — Feeling: Good · Site: Pain, Redness, SwellingFree text: Being uninformed I took Tylenol before having my injection yesterday.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-03
- 2021-03-04
- 2021-03-05
- 2021-03-06
- 2021-03-07
- 2021-03-08
- 2021-03-15
- 2021-03-22
-
2021-03-29
Dose 2 — Moderna
- 2021-03-29
-
2021-03-30
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Joint pains, Muscle or body achesAdult check-in
-
2021-03-31
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Joint pains, Muscle or body achesAdult check-in
-
2021-04-01
Survey response — days 1–6 daily, dose 2MedDRA: Eczema, Pre-existing disease — Feeling: Good · Site: Pain · Joint pains, Muscle or body achesFree text: eczema flare upMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-02
- 2021-04-03
- 2021-04-04
- 2021-04-05
- 2021-04-12
- 2021-04-20
-
2021-04-26
Survey response — day 28, dose 2MedDRA: Pre-existing disease — Feeling: GoodFree text: Worsening eczemaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-03
Survey response — day 35, dose 2MedDRA: Eczema, Pre-existing disease — Feeling: GoodFree text: Worsening eczemaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-10
- 2021-06-28
-
2021-09-27
Survey response — 6 months, dose 2MedDRA: Eczema — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Worsening eczema spread. Unable to get appointment with dermatologist.MedDRA releases: 2024-11 · check-in free text available
-
2021-10-22
Dose 3 — Moderna
-
2021-10-22
Health check-in — day 0, dose 3Feeling: Good · Site: Itching · Rash, not including the immediate area around the injection siteAdult check-in
-
2021-10-23
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Swelling, Itching · Rash, not including the immediate area around the injection siteAdult check-in
-
2021-10-24
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Swelling, Itching · Rash, not including the immediate area around the injection siteAdult check-in
-
2021-10-26
Survey response — days 1–6 daily, dose 3MedDRA: Pruritus, Rash — Feeling: Good · Site: Itching · Rash, not including the immediate area around the injection siteFree text: Worsening eczema on lower legs and ankles, body rashes and itchingMedDRA releases: 2024-11 · check-in free text available
-
2021-10-27
Survey response — days 1–6 daily, dose 3MedDRA: Pruritus, Rash, Rash pruritic — Feeling: Good · Site: Itching · Rash, not including the immediate area around the injection siteFree text: Patches of itching body rash with a pronounced concentration on lower legs and ankles.MedDRA releases: 2024-11 · check-in free text available
-
2021-10-28
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Itching · Rash, not including the immediate area around the injection siteAdult check-in
-
2021-10-29
Health check-in — day 7, dose 3Feeling: Fair · Site: Itching · Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesAdult check-in
- 2021-11-05
-
2021-11-12
Survey response — day 21, dose 3MedDRA: Office visit, Rash — Feeling: Fair · Get care from a doctor or other healthcare professionalFree text: Symptoms: Spreading rash · Healthcare visit (other): Dermatologist officeMedDRA releases: 2024-11 · check-in free text available
-
2021-11-12
Report sent to call center — day 21, dose 3Get care from a doctor or other healthcare professional1 call case(s)
-
2021-11-15
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2021-11-19
- 2021-11-26
- 2021-12-03
- 2022-01-21
-
2022-03-31
Dose 4 — Moderna
- 2022-04-15
- 2022-04-21
-
2022-04-28
Survey response — day 28, dose 4MedDRA: Basal cell carcinoma, Office visit, Surgery — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: Small basil cell carcinoma discovered during annual screening · Healthcare visit (other): Surgical procedure scheduled in-officeMedDRA releases: 2024-11 · check-in free text available
-
2022-04-28
Report sent to call center — day 28, dose 4Get care from a doctor or other healthcare professional1 call case(s)
-
2022-04-29
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2022-05-05
-
2022-05-12
Survey response — day 42, dose 4MedDRA: Office visit, Skin neoplasm excision — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Basel cell carcinoma removed. Biopsy results due next week. · Healthcare visit (other): Dermatologist's officeMedDRA releases: 2024-11 · check-in free text available
-
2022-05-12
Report sent to call center — day 42, dose 4Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2022-05-13
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2022-06-30
- 2022-09-29
- 2023-03-31
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-01 | Moderna | |
| 2 | 2021-03-29 | Moderna | |
| 3 | 2021-10-22 | Moderna | No |
| 4 | 2022-03-31 | Moderna | No |
Call center
3 call center cases
3 successful
Free text
Release 4 — days 1–6 daily, dose 1
Systemic reaction (other): Being uninformed I took Tylenol before having my injection yesterday.
Release 6 — days 1–6 daily, dose 2
Systemic reaction (other): eczema flare up
Release 8 — day 28, dose 2
Symptoms: Worsening eczema
Release 8 — day 35, dose 2
Symptoms: Worsening eczema
Release 9 — 6 months, dose 2
Symptoms: Worsening eczema spread. Unable to get appointment with dermatologist.
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Worsening eczema on lower legs and ankles, body rashes and itching
Systemic reaction (other): Patches of itching body rash with a pronounced concentration on lower legs and ankles.
Release 10 — day 21, dose 3
Release 11 — day 28, dose 4
Symptoms: Small basil cell carcinoma discovered during annual screening
Healthcare visit (other): Surgical procedure scheduled in-office
Release 11 — day 42, dose 4
Symptoms: Basel cell carcinoma removed. Biopsy results due next week.
Healthcare visit (other): Dermatologist's office
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| HCVO | Surgery | · | · | ✓ |
| SD | Basal cell carcinoma | · | · | ✓ |
| SD | Eczema | ✓ | ✓ | ✓ |
| SD | Office visit | · | · | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Rash | · | · | ✓ |
| SD | Skin neoplasm excision | · | · | ✓ |
| SRO | Eczema | ✓ | ✓ | ✓ |
| SRO | No adverse event | ○ | ✓ | ○ |
| SRO | Pre-existing disease | ✓ | ✓ | ✓ |
| SRO | Pruritus | · | · | ✓ |
| SRO | Rash | · | · | ✓ |
| SRO | Rash pruritic | · | · | ✓ |
| SRO | Unevaluable event | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release